Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymosin alpha 1 in allogeneic hematopoietic transplantation
NCT00580450Phase 2Unknown
- Sponsor
- University of Perugia
- Start
- Dec 2007
- Primary completion
- Dec 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of thymosin alpha 1 in Infection, graft-versus-host disease (GVHD), sponsored by University of Perugia. Status: unknown.
02
Drugs
thymosin alpha 1
03
Conditions
Infectiongraft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00580450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00580450.